DNA Script announced the appointment of Marc Montserrat as its new Chief Executive Officer.

DNA Script Closes $200 Million Series C Financing with Completion of Second TrancheAccounts and funds advised by T. Rowe Price Associates, Inc. and Baillie Gifford join syndicate of investors ...

SOUTH SAN FRANCISCO, Calif. and PARIS, April 27, 2021 /PRNewswire/ -- DNA Script today announced a partnership with Moderna, Inc. (Nasdaq: MRNA) to develop a prototype for rapid mobile ...

DNA Script, based in Paris, France, will provide its synthesis technologies—which are used to create the DNA template from which the mRNA transcripts are produced.

DNA SCRIPT SIGNS CONTRACT WITH FRENCH DEPARTMENT OF DEFENCE San Francisco-based DNA synthesis company, DNA Script has announced a partnership with the French Defence Innovation Agency, in liaison with ...

EVA Pharma of Africa, DNA Script and Quantoom Biosciences have signed a memorandum of understanding (MoU) to establish the first digital-to-biologics, end-to-end mRNA production platform in Egypt.

CEPI and DNA Script are also committed to enabling equitable access to the outputs of their collaboration.

DNA Script has not yet contributed any content. In this webinar, Imogen Binnian will share how AI and gene synthesis technology can accelerate the discovery and validation of novel disease traits. The ...

The positions in the table below reflect the DNA Script SAS's position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links to the ...

In this webinar brought to you by DNA Script, Benoit Derrien will showcase different methods for gene construction and will discuss how enzymatic DNA synthesis (EDS) can help researchers overcome ...